304 related articles for article (PubMed ID: 19197166)
1. What will the emperor say? Screening for prostate cancer as of 2008.
Concato J
Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
[TBL] [Abstract][Full Text] [Related]
2. [The unreasonableness of prostate-cancer screening and the ethical problems pertaining to its investigation].
Bonneux L
Ned Tijdschr Geneeskd; 2005 Apr; 149(18):966-71. PubMed ID: 15903036
[TBL] [Abstract][Full Text] [Related]
3. [PSA related screening of prostate cancer. Panic or improvement?].
Fornara P; Jurczok A
Aktuelle Urol; 2004 Feb; 35(1):43-8. PubMed ID: 14997414
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
Hoffman RM
Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
[TBL] [Abstract][Full Text] [Related]
5. [Screening for prostate cancer--what does the evidence show?].
Borre M; Iversen P
Ugeskr Laeger; 2007 May; 169(20):1887-8. PubMed ID: 17553362
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer screening: more harm than good?
Lefevre ML
Am Fam Physician; 1998 Aug; 58(2):432-8. PubMed ID: 9713397
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
9. Economic evaluation of prostate cancer screening with prostate-specific antigen.
Imamura T; Yasunaga H
Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
[TBL] [Abstract][Full Text] [Related]
10. The Japanese guideline for prostate cancer screening.
Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
[TBL] [Abstract][Full Text] [Related]
11. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
12. Rural residence and prostate cancer screening with prostate-specific antigen.
Stamatiou K; Skolarikos A
Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
[TBL] [Abstract][Full Text] [Related]
13. Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Urol Oncol; 2008; 26(5):533-41. PubMed ID: 18774469
[TBL] [Abstract][Full Text] [Related]
14. Guideline update: what's the best approach for screening asymptomatic men for prostate cancer?
Holten KB; Al-Abdulla S
J Fam Pract; 2009 Dec; 58(12):E2. PubMed ID: 19961813
[TBL] [Abstract][Full Text] [Related]
15. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan.
Ito K; Kakehi Y; Naito S; Okuyama A;
Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203
[TBL] [Abstract][Full Text] [Related]
16. [Prostate cancer: update on screening].
Grosclaude P
Bull Acad Natl Med; 2008 May; 192(5):1013-8; discussion 1019. PubMed ID: 19238790
[TBL] [Abstract][Full Text] [Related]
17. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
18. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
Howard K; Barratt A; Mann GJ; Patel MI
Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
[TBL] [Abstract][Full Text] [Related]
19. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
20. Prostate cancer: to screen or not to screen?
Shteynshlyuger A; Andriole GL
Urol Clin North Am; 2010 Feb; 37(1):1-9, Table of Contents. PubMed ID: 20152514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]